SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
keyangtong
Lv1
60 积分
2023-01-29 加入
最近求助
最近应助
互助留言
Toxicities From Antibody-Drug Conjugates
10天前
已完结
Chemotherapy and Osimertinib Combination Should Not Be the First-Line Treatment for All Advanced EGFR+ NSCLC
19天前
已完结
Targeting the IL1β Pathway for Cancer Immunotherapy Remodels the Tumor Microenvironment and Enhances Antitumor Immune Responses
28天前
已完结
TREX1 inactivation unleashes cancer cell STING-interferon signaling and promotes anti-tumor immunity
1个月前
已完结
Lung cancer oncogene-directed therapy, fertility and pregnancy
3个月前
已关闭
Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US
3个月前
已完结
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial
6个月前
已完结
The Accelerated Approval Program for Cancer Drugs — Finding the Right Balance
6个月前
已完结
The Treatment of a New Entity in Advanced Non-Small Cell Lung Cancer: MET exon 14 Skipping Mutation
8个月前
已关闭
Real-World Treatment Outcomes of MET Exon14 Skipping in Non-small Cell Lung Cancer: GFPC 03-18 Study
8个月前
已完结
没有进行任何应助
不需要【积分已退回】
3个月前
速度真快,感谢
8个月前
速度真快
11个月前
感谢
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论